Home › Funds › OGOREK ANTHONY JOSEPH /NY/ /ADV › DNOV

OGOREK ANTHONY JOSEPH /NY/ /ADV position in DNOV

FIRST TR EXCHNG TRADED FD VI

OGOREK ANTHONY JOSEPH /NY/ /ADV reported holding 163,814 shares of DNOV (FIRST TR EXCHNG TRADED FD VI) in its Q3 2026 13F filing — a position valued at US$8.6M, representing 2.14% of its reported portfolio and ranking #15 among its reported holdings. OGOREK ANTHONY JOSEPH /NY/ /ADV has disclosed DNOV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)163.81K sh
Reported value held$8.63M
Portfolio Weight2.14%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How OGOREK ANTHONY JOSEPH /NY/ /ADV's DNOV position evolved

OGOREK ANTHONY JOSEPH /NY/ /ADV first disclosed a stake in DNOV in Q3 2023 at 163,123 shares (US$5.8M). The position peaked in Q2 2026 at 185,611 shares, worth US$9.5M. Across 13 filings, OGOREK ANTHONY JOSEPH /NY/ /ADV increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 163,814 shares valued at US$8.6M — a reduction of -21,797 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 163.12K $5.79M New
Q4 2023 163.12K $6.32M Hold
Q1 2024 163.12K $6.59M Hold
Q2 2024 162.91K $6.75M Hold
Q3 2024 162.91K $6.87M Hold
Q4 2024 174.86K $7.50M Add
Q1 2025 177.05K $7.42M Add
Q2 2025 173.57K $7.76M Reduce
Q3 2025 173.19K $8.11M Hold
Q4 2025 186.42K $9.10M Add
Q1 2026 185.90K $8.90M Hold
Q2 2026 185.61K $9.53M Hold
Q3 2026 163.81K $8.63M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DNOV and 13F data

DNOV (FIRST TR EXCHNG TRADED FD VI) is a company whose sector is not yet classified in our data. 26 other funds we track also report a position in DNOV — the largest reported positions include REAP Financial Group, LLC (US$5.2M), WINNACLE WEALTH LLC (US$4.5M), Echo Wealth Management, LLC (US$3.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DNOV

All DNOV fund holders →

FAQ

How long has OGOREK ANTHONY JOSEPH /NY/ /ADV held DNOV?

OGOREK ANTHONY JOSEPH /NY/ /ADV has disclosed DNOV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is OGOREK ANTHONY JOSEPH /NY/ /ADV's current position in DNOV?

As of Q3 2026, OGOREK ANTHONY JOSEPH /NY/ /ADV holds 163.81K shares of DNOV (FIRST TR EXCHNG TRADED FD VI), valued at $8.63M, representing 2.14% of its reported portfolio and ranking #15.

Has OGOREK ANTHONY JOSEPH /NY/ /ADV been buying or selling DNOV?

In the latest 13F filing (Q3 2026), OGOREK ANTHONY JOSEPH /NY/ /ADV reduced its position in DNOV. The position peaked in Q2 2026 at 185.61K shares.

Which other funds hold DNOV?

Other major institutional holders of DNOV include REAP Financial Group, LLC, WINNACLE WEALTH LLC, Echo Wealth Management, LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.